Trastuzumab upregulates PD-L1 as a potential mechanism of trastuzumab resistance through engagement of immune effector cells and stimulation of IFNγ secretion
Author:
Funder
National Institutes of Health
Foundation for the National Institutes of Health
Breast Cancer Research Foundation
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference64 articles.
1. Trastuzumab in the treatment of breast cancer;Hortobagyi;N. Engl. J. Med.,2005
2. Trastuzumab–mechanism of action and use in clinical practice;Hudis;N. Engl. J. Med.,2007
3. Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer;Swain;N. Engl. J. Med.,2015
4. First-line therapy in HER2 positive metastatic breast cancer: is the mosaic fully completed or are we missing additional pieces?;Fabi;J. Exp. Clin. Canc. Res.,2016
5. Interplay between natural killer cells and anti-HER2 antibodies: perspectives for breast cancer immunotherapy;Muntasell;Front. Immunol.,2017
Cited by 114 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The association of PD-L1 expression and CD8-positive T cell infiltration rate with the pathological complete response after neoadjuvant treatment in HER2-positive breast cancer;Breast Cancer Research and Treatment;2024-01-25
2. Galectin-9 in cancer therapy: from immune checkpoint ligand to promising therapeutic target;Frontiers in Cell and Developmental Biology;2024-01-09
3. Emerging Targets for Systemic Treatment of Gastric Cancer: HER2 and Beyond;Journal of Gastric Cancer;2024
4. Preclinical and Clinical Observations Implying Combination Therapy to Enhance the Efficacy of the Her-2/neu B-Cell Peptide-Based Vaccine HER-Vaxx and to Prevent Immune Evasion;International Journal of Molecular Sciences;2023-12-24
5. Generation and Characterization of Trastuzumab/Pertuzumab-Resistant HER2-Positive Breast Cancer Cell Lines;International Journal of Molecular Sciences;2023-12-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3